Skip to main content
TipRanks
Go Ultimate75% OFF

fureasu Co., Ltd. (7062) AI Stock Analysis

0 Followers
JP:7062

fureasu Co., Ltd.

(TSE/TYO:7062)

Select Model
Rating:62Neutral
Price Target:JPY 714.00â–²(5.93% Upside)
Action:reiterated
Date:11/18/26

The score is led by improved financial performance (profit rebound, stronger margins, major debt reduction, and solid free cash flow) and supported by attractive valuation (low P/E and a dividend). These positives are tempered by weak-to-neutral technical signals and fundamental durability risks from declining revenue and historically volatile cash flow.

Positive Factors
DeleveragingThe sharp reduction in debt materially strengthens Fureasu’s capital structure and lowers financial strain compared with the prior year. Greater balance-sheet flexibility can support ongoing operations and investment, while reducing the extent to which weaker periods could threaten liquidity or constrain management’s choices.
Negative Factors
Revenue ContractionRevenue contraction is a fundamental concern because it indicates that the earnings rebound occurred without corresponding top-line expansion. Continued lower volume or demand could limit operating leverage, make fixed costs harder to absorb, and reduce the durability of the recent profit improvement over the next several quarters.

fureasu Co., Ltd. (7062) vs. iShares MSCI Japan ETF (EWJ)

-20%-10%0%10%20%30%JP:7062-14.14%EWJ+14.66%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 1.72B
Dividend Yield
1.57%
Average Volume (3M)
3,891
Price to Earnings (P/E)
4.8
Beta (1Y)
0.73
Revenue Growth
-27.05%
EPS Growth
387.17%
Country
Japan
Employees
761
Sector
General
Sector Strength
55
Industry
Medical - Care Facilities

fureasu Co., Ltd. Business Overview & Revenue Model

Company Description

Fureasu Co.,Ltd. is a Japanese company specializing in therapeutic massage services, massage franchise operations, and a diverse range of care solutions. Its therapeutic offerings encompass in-home acupuncture, moxibustion treatments, on-site corpora...

How the Company Makes Money

Fureasu Co., Ltd. primarily makes money by charging for home-visit treatment services (e.g., acupuncture/moxibustion) delivered to clients; revenue is generated when a practitioner visit is performed and billed. The company also earns revenue through...

fureasu Co., Ltd. Financial Statement Overview

Summary

FY2026 showed a clear recovery: net income turned positive (Â¥509M), operating profit returned, gross margin improved (~45% vs. ~42%), debt was reduced sharply, and free cash flow was strong (~Â¥564M) and closely tracked earnings. Offsetting strengths include an 8.2% revenue decline and historically volatile operating/free cash flow (negative in FY2025 and FY2023), raising questions about durability.

Income Statement

62Positive

Balance Sheet

68Positive

Cash Flow

58Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue6.85B7.64B7.58B5.71B4.58B4.17B
Gross Profit3.29B3.46B3.20B2.69B2.24B2.08B
EBITDA956.16M482.72M200.26M319.35M200.51M332.47M
Net Income604.17M508.92M-244.55M58.30M31.59M147.85M
Balance Sheet
Total Assets5.19B5.39B8.70B6.19B4.54B3.39B
Cash, Cash Equivalents and Short-Term Investments1.36B1.62B815.00M1.13B975.26M1.21B
Total Debt2.03B2.14B6.14B3.48B2.09B995.35M
Total Liabilities3.01B3.21B7.15B4.43B2.81B1.67B
Stockholders Equity2.18B2.18B1.55B1.77B1.73B1.72B
Cash Flow
Free Cash Flow0564.46M-456.86M41.91M-317.08M166.38M
Operating Cash Flow0590.56M-319.20M172.02M-233.15M309.27M
Investing Cash Flow0801.62M-354.88M-193.60M-516.91M-149.47M
Financing Cash Flow0-589.96M358.26M177.13M511.11M-160.97M

fureasu Co., Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price674.00

Price Trends

50DMA682.02Negative
100DMA720.17Negative
200DMA773.57Negative

Market Momentum

MACD-3.38Negative
RSI46.50Neutral
STOCH75.61Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7062, the sentiment is Negative. The current price of 674.00 is below the 20-day moving average (MA) of 676.25, below the 50-day MA of 682.02, and below the 200-day MA of 773.57, indicating a bearish trend. The MACD of -3.38 indicates Negative momentum. The RSI at 46.50 is Neutral, neither overbought nor oversold. The STOCH value of 75.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7062.

fureasu Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:7062 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:9262JP:926274OutperformJPY 6.95B8.39―2.83%8.68%16.99%
JP:7358JP:735871OutperformJPY 16.39B10.36―2.66%8.02%47.33%
JP:7062JP:706262NeutralJPY 1.76B4.84―1.57%-27.05%387.17%
JP:7040JP:704061NeutralJPY 5.71B11.09―3.76%0.57%-38.90%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:4331JP:433150NeutralJPY 11.79B61.95―6.29%――

* General Sector Average

Performance Comparison

-20%0%20%40%JP:7062JP:4331JP:7040JP:7358JP:9262Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7062 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7062fureasu Co., Ltd.674.00-112.00-14.25%
JP:4331Take and Give. Needs Co., Ltd.811.0093.5113.03%
JP:7040SUN-LIFE HOLDING CO., LTD.932.0012.481.36%
JP:7358Poppins Corporation1690.00378.2128.83%
JP:9262SILVER LIFE CO.,LTD.635.00-197.20-23.70%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 18, 2026